Literature DB >> 22038158

[(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model.

Lin Xie1, Tomoteru Yamasaki, Naotsugu Ichimaru, Joji Yui, Kazunori Kawamura, Katsushi Kumata, Akiko Hatori, Norio Nonomura, Ming-Rong Zhang, Xiao-Kang Li, Shiro Takahara.   

Abstract

Neuroimaging measures have potential for monitoring neuroinflammation to guide treatment before the occurrence of significant functional impairment or irreversible neuronal damage in multiple sclerosis (MS). N-Benzyl-N-methyl-2-(7-[(11)C]methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl) acetamide ([(11)C]DAC), a new developed positron emission tomography (PET) probe for translocator protein 18 kDa (TSPO), has been adopted to evaluate the neuroinflammation and treatment effects of experimental autoimmune encephalomyelitis (EAE), an animal model of MS. [(11)C]DAC-PET enabled visualization of neuroinflammation lesion of EAE by tracing TSPO expression in the spinal cords; the maximal uptake value reached in day 11 and 20 EAE rats with profound inflammatory cell infiltration compared with control, day 0 and 60 EAE rats. Biodistribution studies and in vitro autoradiography confirmed these in vivo imaging results. Doubling immunohistochemical studies showed the infiltration and expansion of CD4+ T cells and CD11b+ microglia; CD68+ macrophages were responsible for the increased TSPO levels visualized by [(11)C]DAC-PET. Furthermore, mRNA level analysis of the cytokines by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) revealed that TSPO+/CD4 T cells, TSPO+ microglia and TSPO+ macrophages in EAE spinal cords were activated and secreted multiple proinflammation cytokines to mediate inflammation lesions of EAE. EAE rats treated with an immunosuppressive agent: 2-amino-2-[2-(4-octylphenyl)ethyl] propane-1,3-diolhydrochloride (FTY720), which exhibited an absence of inflammatory cell infiltrates, displaying a faint radioactive signal compared with the high accumulation of untreated EAE rats. These results indicated that [(11)C] DAC-PET imaging is a sensitive tool for noninvasively monitoring the neuroinflammation response and evaluating therapeutic interventions in EAE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038158     DOI: 10.1007/s11481-011-9322-3

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  55 in total

1.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

2.  Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram.

Authors:  D Agnello; L Carvelli; V Muzio; P Villa; B Bottazzi; N Polentarutti; T Mennini; A Mantovani; P Ghezzi
Journal:  J Neuroimmunol       Date:  2000-09-22       Impact factor: 3.478

3.  Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets.

Authors:  M Letizia Trincavelli; Lorella Marselli; Alessandra Falleni; Vittorio Gremigni; Esther Ragge; Francesco Dotta; Carmela Santangelo; Piero Marchetti; Antonio Lucacchini; Claudia Martini
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

4.  Up-regulation of mitochondrial peripheral benzodiazepine receptor expression by tumor necrosis factor alpha in testicular leydig cells. Possible involvement in cell survival.

Authors:  C Rey; C Mauduit; O Naureils; M Benahmed; P Louisot; F Gasnier
Journal:  Biochem Pharmacol       Date:  2000-12-01       Impact factor: 5.858

Review 5.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 6.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Prog Neurobiol       Date:  2006-12-06       Impact factor: 11.685

7.  Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat.

Authors:  Kazuhiko Yanamoto; Tomoteru Yamasaki; Katsushi Kumata; Joji Yui; Chika Odawara; Kazunori Kawamura; Akiko Hatori; Osamu Inoue; Masatoshi Yamaguchi; Kazutoshi Suzuki; Ming-Rong Zhang
Journal:  Synapse       Date:  2009-11       Impact factor: 2.562

8.  Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro.

Authors:  H Wilms; J Claasen; C Röhl; J Sievers; G Deuschl; R Lucius
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

9.  Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor.

Authors:  Francisco J Quintana; Alexandre S Basso; Antonio H Iglesias; Thomas Korn; Mauricio F Farez; Estelle Bettelli; Mario Caccamo; Mohamed Oukka; Howard L Weiner
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

Review 10.  Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.

Authors:  Jerold Chun; Hans-Peter Hartung
Journal:  Clin Neuropharmacol       Date:  2010 Mar-Apr       Impact factor: 1.592

View more
  8 in total

1.  Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.

Authors:  Yong Wang; Peng Sun; Qing Wang; Kathryn Trinkaus; Robert E Schmidt; Robert T Naismith; Anne H Cross; Sheng-Kwei Song
Journal:  Brain       Date:  2015-02-26       Impact factor: 13.501

2.  In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.

Authors:  Abraham Martín; Nuria Vázquez-Villoldo; Vanessa Gómez-Vallejo; Daniel Padro; Federico N Soria; Boguslaw Szczupak; Sandra Plaza-García; Ander Arrieta; Torsten Reese; Jordi Llop; Maria Domercq; Carlos Matute
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-10       Impact factor: 9.236

Review 3.  PET imaging in multiple sclerosis.

Authors:  Daniele de Paula Faria; Sjef Copray; Carlos Buchpiguel; Rudi Dierckx; Erik de Vries
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-09       Impact factor: 4.147

4.  Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.

Authors:  T Notter; J M Coughlin; T Gschwind; U Weber-Stadlbauer; Y Wang; M Kassiou; A C Vernon; D Benke; M G Pomper; A Sawa; U Meyer
Journal:  Mol Psychiatry       Date:  2017-01-17       Impact factor: 15.992

5.  Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis.

Authors:  David Vállez García; Janine Doorduin; Daniele de Paula Faria; Rudi A J O Dierckx; Erik F J de Vries
Journal:  J Neuroimmune Pharmacol       Date:  2017-03-30       Impact factor: 4.147

6.  Diffusion Basis Spectrum and Diffusion Tensor Imaging Detect Hippocampal Inflammation and Dendritic Injury in a Virus-Induced Mouse Model of Epilepsy.

Authors:  Jie Zhan; Tsen-Hsuan Lin; Jane E Libbey; Peng Sun; Zezhong Ye; Chunyu Song; Michael Wallendorf; Honghan Gong; Robert S Fujinami; Sheng-Kwei Song
Journal:  Front Neurosci       Date:  2018-02-15       Impact factor: 4.677

7.  Identifying early inflammatory changes in monocyte-derived macrophages from a population with IQ-discrepant episodic memory.

Authors:  Eric J Downer; Raasay S Jones; Claire L McDonald; Eleonora Greco; Sabina Brennan; Thomas J Connor; Ian H Robertson; Marina A Lynch
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

Review 8.  PET imaging of inflammation biomarkers.

Authors:  Chenxi Wu; Fang Li; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2013-06-24       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.